Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Goetz

Showing results (511-520 of 754) with videos related to

Pageof 76
Sort By:
Journal of the American Academy of Child and Adolescent Psychiatry|March 14, 2000
Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot studyF R Sallee, R Kurlan, C G Goetz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 13, 2016
Gender-, age-, and race/ethnicity-based differential item functioning analysis of the movement disorder society-sponsored revision of the Unified Parkinson's disease rating scaleChristopher G Goetz, Yuanyuan Liu, Glenn T Stebbins, et al.
Biochemical and Biophysical Research Communications|August 12, 2004
The gene product of the gp78/AMFR ubiquitin E3 ligase cDNA is selectively recognized by the 3F3A antibody within a subdomain of the endoplasmic reticulumMarilyn Registre, Jacky G Goetz, Pascal St Pierre, et al.
Nanoscale Advances|October 6, 2025
Functionalization of lipid nanoemulsions with humanized antibodies using plug-and-play cholesterol anchor for targeting cancer cellsValeria Jose Boide-Trujillo, Vincent Mittelheisser, Fei Liu, et al.
JBI Evidence Synthesis|August 27, 2021
Rating scales for medication adherence in people living with Parkinson's disease: a systematic review protocolMichelle Hyczy S Tosin, Beatriz Guitton R B de Oliveira, Christopher G Goetz, et al.
Public Opinion Quarterly|January 6, 1984
Media and agenda setting: effects on the public, interest group leaders, policy makers, and policyF L Cook, T R Tyler, E G Goetz, et al.
Neurology|September 1, 1993
Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuationsM C Kurth, J W Tetrud, C M Tanner, et al.
Neurology|July 1, 1988
Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuationsC G Goetz, C M Tanner, K M Shannon, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 25, 2017
Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double-blind, placebo-controlled multicenter studyChristopher G Goetz, Glenn T Stebbins, Kathryn A Chung, et al.
Parkinsonism & Related Disorders|October 25, 2011
Subject-investigator reproducibility of the Unified Parkinson's Disease Rating ScaleSydney E Seidel, Barbara C Tilley, Peng Huang, et al.
Pageof 76

Showing results (511-520 of 754) with videos related to

Sort By:
Pageof 76
Journal of the American Academy of Child and Adolescent Psychiatry|March 14, 2000
Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot studyF R Sallee, R Kurlan, C G Goetz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 13, 2016
Gender-, age-, and race/ethnicity-based differential item functioning analysis of the movement disorder society-sponsored revision of the Unified Parkinson's disease rating scaleChristopher G Goetz, Yuanyuan Liu, Glenn T Stebbins, et al.
Biochemical and Biophysical Research Communications|August 12, 2004
The gene product of the gp78/AMFR ubiquitin E3 ligase cDNA is selectively recognized by the 3F3A antibody within a subdomain of the endoplasmic reticulumMarilyn Registre, Jacky G Goetz, Pascal St Pierre, et al.
Nanoscale Advances|October 6, 2025
Functionalization of lipid nanoemulsions with humanized antibodies using plug-and-play cholesterol anchor for targeting cancer cellsValeria Jose Boide-Trujillo, Vincent Mittelheisser, Fei Liu, et al.
JBI Evidence Synthesis|August 27, 2021
Rating scales for medication adherence in people living with Parkinson's disease: a systematic review protocolMichelle Hyczy S Tosin, Beatriz Guitton R B de Oliveira, Christopher G Goetz, et al.
Public Opinion Quarterly|January 6, 1984
Media and agenda setting: effects on the public, interest group leaders, policy makers, and policyF L Cook, T R Tyler, E G Goetz, et al.
Neurology|September 1, 1993
Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuationsM C Kurth, J W Tetrud, C M Tanner, et al.
Neurology|July 1, 1988
Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuationsC G Goetz, C M Tanner, K M Shannon, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 25, 2017
Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double-blind, placebo-controlled multicenter studyChristopher G Goetz, Glenn T Stebbins, Kathryn A Chung, et al.
Parkinsonism & Related Disorders|October 25, 2011
Subject-investigator reproducibility of the Unified Parkinson's Disease Rating ScaleSydney E Seidel, Barbara C Tilley, Peng Huang, et al.
Pageof 76